Differing Effects of Antipsychotic Medications on Substance Abuse Treatment Patients with Co-occurring Psychotic and Substance Abuse Disorders

REFERENCES

• Simpson DD, Sells SB. Effectiveness of treatment for drug abuse: an overview of the DARP research program. Advances in Alcohol and Substance Abuse. 1982;2:7–29. [CSA]
   Google Scholar
• Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: The University of North Carolina Press; 1989.
   Google Scholar
• Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of one-year follow-up in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11:261–278. [CSA], [CROSSREF]
   Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264:2511–2518. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001;52:469–476. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Owen RR, Fischer EP, Booth BM, , et al. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv. 1996;47:853–858. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hughes JR, Hatsukami DK, Mitchell JE, , et al. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143:993–997. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Stuyt EB. Recovery rates after treatment for alcohol/drug dependence, tobacco users vs. non-tobacco users. Am J Addict. 1997;6:159–167. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Reid MS, Michalian JD, Delucchi KL, Hall SM, Berger SP. An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend. 1998;49:95–104. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Frosch DL, Nahom D, Shoptaw S, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp Clin Psychopharmacol. 2000;8:97–103. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buckley PF. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat. 1998;15:113–116. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Drake RE, Xie H, McHugo GJ, , et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull. 2000;26:441–449. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Zimmet SV, Strous RD, Burgess ES, , et al. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol. 2000;20:94–98. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Albanese MJ. Safety and efficacy of risperidone in substance abusers with psychoses. Am J Addict. 2001;10:190–191. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gupta N, Basu D. Does risperidone reduce concomitant substance abuse in cases of schizophrenia? Can J Psychiatry. 2001;46:862–863. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. (Letter.) Can J Psychiatry. 1997;42:431. [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Littrell KH, Petty RG, Hilligoss NM, , et al. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat. 2001;21:217–221. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Noordsy DL, O'Keefe C. Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a community mental health center setting. J Clin Psychiatry. 1999;60(suppl. 19):47–51. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Noordsy DL, O'Keefe C, Mueser KT, , et al. Six-month outcomes for patients who switched to olanzapine treatment. Psychiatr Serv. 2001;52:501–507. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002;4:406–411. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Avants SK, Margolin A, Holford TR, , et al. A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med. 2000;160:2305–2312. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Prochaska JO, Diclementi CC, Norcross JC. Changing for Good. New York, NY: Basic Books; 1986.
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
   Google Scholar
• SAS Institute Inc. StatView® 5 Reference. Cary, NC: SAS Institute Inc.; 1998.
   Google Scholar
• Davis JM, Chen MC, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553–564. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bilder RM, Goldman RS, Volavka J, , et al. Neurocognitive effects of clozapine, olanzapine, risperidone and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002;159:1018–1028. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Purdon SE, Jones BDW, Stip E, , et al. Neuropsychological change in early phase schizophrenia during twelve months of treatment with olanzapine, risperidone or haloperidol. Arch Gen Psychiatry. 2000;57:249–258. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15:469–494. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zullino DF, Delessert D, Eap CB, , et al. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol. 2002;17:141–143. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 1995;56:344–346. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Vartian BA, Hawken ER, Delva NJ. Spontaneous long-term smoking cessation in a patient with schizophrenia after treatment with ziprasidone. Addict Disord Their Treatment. 2004;3:138–143. [CSA], [CROSSREF]
   Google Scholar
• Smelson DA, Losonczy MF, Davis CW, , et al. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002;47:671–675. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kampman KM, Pettinati H, Lynch KG, , et al. A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend. 2003;70:265–273. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar